Ok, scrolled down and read the response. I also respect your opinion, and have some concerns although I never was that enthused about rida but have a lot of faith in Ponatinib, so the rida fiasco was , to me, not a huge surprise . The fact that berger engineered a pretty favorable change of terms prior to that event has bolstered his standing in my opinion. Clacksons sales were mostly automatic I believe, planned well in advance which should argue against insider knowledge of incipient bad news, correct? Still, the timing is interesting, suggesting clackson anticipates a post Asco selloff which I think if we are honest about it, most of us do as well. The question then becomes do we ride out a post Asco selloff in anticipation of future positive catalysts, or take profits now. I guess there are an infinite number of variables that will decide that for each one of us.